|
|
European High Throughput Screening (HTS) MarketPublished by: Frost & Sullivan Published: May. 21, 2007 - 142 Pages Table of Contents1. Executive Summary 1. Overview 1. Executive Summary 2. Exchange Rates and Glossary of Terms 1. Glossary of Terms 1. Glossary of Terms 2. Exchange Rates 1. Exchange Rates 3. Industry Challenges 1. Research Scope and Methodology 1. Research Scope and Methodology 2. Industry Challenges 1. Industry Challenges 4. Total European High Throughput Screening (HTS) Market 1. Technology Trends 1. Introduction 2. Technology Trends 3. Technology Drivers 4. Technology Restraints 2. Market Overview 1. Market Overview 2. Market Engineering Measurements 3. Market Drivers a. Demand for Newer Drugs b. Investments in R&D c. Increasing Technological Innovations d. Increasing Drug Targets e. Improving Quality Screening 4. Market Restraints a. Time Consuming Process b. High Costs c. Lack of Manpower d. Uncertainty in Results 5. Total Revenue Forecasts 6. Pricing Trends 7. Competitive Analysis 8. Geographical Trends 9. End-user Analysis 5. German High Throughput Screening (HTS) Market 1. Market Engineering Research 1. Market Engineering Measurements 2. Total Revenue Forecasts 3. Competitive Landscape 6. French High Throughput Screening (HTS) Market 1. Market Engineering Research 1. Market Engineering Measurements 2. Total Revenue Forecasts 3. Competitive Landscape 7. The United Kingdom High Throughput Screening (HTS) Market 1. Market Engineering Research 1. Market Engineering Measurements 2. Total Revenue Forecasts 3. Competitive Landscape 8. Italian High Throughput Screening (HTS) Market 1. Market Engineering Research 1. Market Engineering Measurements 2. Total Revenue Forecasts 9. Benelux High Throughput Screening (HTS) Market 1. Market Engineering Research 1. Market Engineering Measurements 2. Total Revenue Forecasts 10. Scandinavian High Throughput Screening (HTS) Market 1. Market Engineering Research 1. Market Engineering Measurements 2. Total Revenue Forecasts 11. Spanish High Throughput Screening (HTS) Market 1. Market Engineering Research 1. Market Engineering Measurements 2. Total Revenue Forecasts 12. Strategic Recommendations 1. Strategic Recommendations 1. Strategic recommendations 13. Decision Support Database 1. Decision Support Database 1. Total Population 2. Government R&D Investments in Biotechnology 3. Pharmaceutical R&D Expenditure 4. Percentage of Pharmaceutical R&D Expenditure 5. Total Healthcare Expenditure 14. Database of Key Industry Participants 1. Database of Key Industry Participants 1. Database of Key Industry Participants
AbstractResearch OverviewThis Frost & Sullivan research service titled European High Throughput Screening Markets provides an overview of the current state as well as future of the market along with revenues. It provides a complete analysis of key market drivers, restraints and trends and also offers strategic solutions to help companies gain competitive advantage in this growing market. In this research service, Frost & Sullivan's expert analysts thoroughly examine the markets for HTS instruments and HTS consumables. Market Sectors Expert Frost & Sullivan analysts thoroughly examine the following market sectors in this research: The following technologies are covered in this research: HTS Market Experiences Strong Growth but Tends toward Maturity High throughput screening (HTS) technologies have been widely accepted by pharmaceuticals and biotechnology companies as an integral part of their drug discovery processes and the European HTS market is currently in a growth phase. Despite the initial high acceptance levels, recent trends point to a growing maturity in the market with practically all drug discovery companies, big and small, having adopted it in their laboratories. However, continuous technological innovation is doing much to sustain market growth. The incorporation of software into HTS instruments, for instance, has revolutionised the market by simplifying the drug discovery process and enabling the development of more novel drugs along with the target ones. Researchers prefer to use sophisticated instruments in the laboratory for these reasons and this is leading to intense competition as manufacturers attempt to meet those needs. "There is much scope for technological innovation in the HTS market, particularly since end users welcome such improvements," says the analyst of this research service. "Manufacturers are ensuring that their instruments adhere to industry standards and are increasing R&D investment for continued innovation." Typically, the larger market participants launch new models and get them patented to avoid replication. Many manufacturers are targeting pharmaceuticals companies for the sale of HTS instruments due to their higher use of this technology. Some newer entrants are focusing on universities and private laboratories as potential end users of HTS technology. While HTS forms a part of universities’ academic research, private laboratories use this technology for projects outsourced to them by pharmaceuticals and biotechnology companies. Technological Advancements Revolutionise the Market HTS reagents and assays are experiencing increasing demand, leading to intense competition among reagent manufacturers, much more than among instrument manufacturers. Many new market entrants are attempting to gain some market share by focussing on a niche clientele initially and later expanding their customer base. Technological advancements such as the use of robotics and cell-based assays have had a significant impact on the HTS market. Implementing robotics and automation into HTS, for instance, has enhanced the efficiency of procedures, allowing researchers to achieve high screening rates using relatively less time and resources. Cell-based assays are also gaining popularity with end users preferring them over conventional assays. Cell-based assays can be used to test compounds directly on living cells, which helps generate quality leads as well as hastens the process of lead validation. Biochemical assays are seeing increasing usage for compound identification, while high-content screening - an extended version of HTS - is also being used more frequently to screen a larger number of compound libraries. Get Full Details About This Report >> |
|
|||
|
About MarketResearch.com
|
||||